US EditionBarclays PLC Trims Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Summary by americanbankingnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Barclays PLC Trims Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Barclays PLC lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 6.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 237,941 shares of the company’s stock after selling 15,451 shares during the quarter. Barclays PLC owned about 0.20% […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
